Tetraphase Pharmaceuticals Announces FDA Approval of XERAVA(TM) (Eravacycline) for Complicated Intra-Abdominal Infections (cIAI)

Stock Information for Tetraphase Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.